Statewide Lung Cancer Screening Improvement in Nevada and Mississippi using the QUILS System

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional effort uses a statewide implementation approach to scale and sustain lung cancer screening through the QUILS SBI intervention in Mississippi and Nevada. The study targets state-based teams and leadership groups involved in lung cancer screening to translate prior Kentucky success into broader practice. It focuses on improving capacity, equity, and uptake of screening among eligible populations, with assessments of implementation activity and outcomes. Sites include Delta Health System, Greenwood Leflore Hospital, and Memorial Hospital Gulfport in Mississippi. No clinical patient-level randomization or efficacy comparisons are described in the available details.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Member of a state-based lung cancer screening implementation team in Mississippi or Nevada.
* Leadership member of the Mississippi state team or Nevada state team
* Active member of the Mississippi Lung Cancer Roundtable (MSLCRT) or Nevada Lung Cancer Coalition (NLCC)
* Willing to participate in study-related assessments an implementation activities

Exclusion Criteria:

* None

Where it's running

• Delta Health System
  Greenville, Mississippi, United States Recruiting
• Greenwood Leflore Hospital
  Greenwood, Mississippi, United States Recruiting
• Memorial Hospital Gulfport
  Gulfport, Mississippi, United States Recruiting
• Hattiesburg Clinic
  Hattiesburg, Mississippi, United States Recruiting
• University of Mississippi Medical Center
  Jackson, Mississippi, United States Recruiting
• Baptist Memorial Hospital
  New Albany, Mississippi, United States Recruiting

Study contacts

• Study coordinator: Joseph Alexander, MD
• Email: joseph.alexander@uky.edu
• Phone: 8593230892

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Empowering patients to get lung cancer screening with support and navigation

  This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.

  Recruiting at 13 sites University of California, Irvine · Anaheim, California and 56 other locations · NCT07711691

• Quality Implementation of Lung Cancer Screening in Kentucky

  This project tests how well the QUILS system helps Kentucky lung cancer screening programs work together to screen at-risk residents more effectively.

  Recruiting at 17 sites University of Kentucky · Ashland, Kentucky and 16 other locations · NCT07682610

• Quality Improvement Implementation for Lung Cancer Screening (QUILS) Program Enhancement

  This project tests a quality improvement pathway in existing lung cancer screening programs to help identify and prioritize process changes that improve quality and patient retention.

  Recruiting at 17 sites University of Kentucky · Ashland, Kentucky and 16 other locations · NCT07639255

• Methylation markers from saliva to guide lung cancer screening

  This study tests whether DNA methylation patterns in saliva can more accurately identify people who should get a low-dose CT scan for lung cancer screening.

  Recruiting University Hospital, Antwerp · Antwerp, Antwerpen · NCT07631624

• Multilevel program to increase LDCT lung cancer screening and help African American smokers quit

  This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.

  Recruiting at 2 sites Louisiana State University Health Sciences Center in New Orleans · New Orleans, Louisiana and 1 other locations · NCT07576595

• Precision lung cancer screening using AI risk scores and blood biomarkers

  This project will test whether the Sybil AI tool and optional blood tests can better predict lung cancer risk for people aged 50–80 getting low-dose CT scans, including those who meet expanded screening rules beyond current USPSTF guidance.

  Recruiting at 2 sites University of Illinois Chicago · Chicago, Illinois and 1 other locations · NCT07408531

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.